Henoch-Schonlein Purpura Nephritis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Henoch-Schonlein Purpura Nephritis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

RecruitingPhase 3

NCT07024563

Study of Ravulizumab in Pediatric Participants With Primary IgAN

The primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy follow…

United States, China, Italy24 participantsStarted 2025-06-14

Treatment: Ravulizumab

RecruitingPhase 2

NCT05003986

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

To evaluate the safety, efficacy and tolerability of sparsentan oral suspension and tablets, and assess changes in proteinuria after once-daily dosing over 108…

United States67 participantsStarted 2021-08-12

Treatment: Sparsentan, Sparsentan

RecruitingPhase 4

NCT06676384

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope o…

Global Burden of Diseases ranks chronic kidney disease (CKD) as the 12th leading cause of death, with an estimated 20% increase from 2010 to 2019. India is the…

India585 participantsStarted 2025-02-15

Treatment: Oral prednisolone and SoC, Gut-directed budesonide and SoC

All recent trials (11 shown)

Not Yet RecruitingNot Applicable

NCT07354503

Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis

To further evaluate the efficacy and safety of Telitacicept in the treatment of pediatric IgA vasculitis nephritis (IgAVN) within real-world settings, this stud…

Location not specified300 participantsStarted 2026-01-01

Treatment: Collect clinical data from the patients., This study exclusively prospectively collected clinical data from the patients and did not involve any therapeutic interventions

UnknownPhase 2

NCT02532790

The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children

This study is performed to evaluate the efficacy and safety of various measures in the treatment of HSPN with mild proteinuria in children.

China100 participantsStarted 2015-08

Treatment:

Henoch-Schonlein Purpura Nephritis

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope o…

All recent trials (11 shown)

Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis

The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children

Trial phase breakdown

Trial status

Actively recruiting — 3 trials

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope o…

All recent trials (11 shown)

Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis

The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children

The Research of Standard Diagnosis and Treatment for HSPN in Children

Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis

Tonsillectomy and Primitive IgA Nephropathy in Children: Strasbourg Cohort and Assessment Practices in Inter North East…

IgA-positive Versus IgA-negative Immune Complex Vasculitis

HSP-glomerulonephritis Trial: MP vs CyA

Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPN